Malignant Ovarian Epithelial Tumor
5 clinical trials · Condition
◉ Watch Malignant Ovarian Epithelial Tumor
| Record | Firm | Date |
|---|---|---|
| ONC201 Plus Weekly Paclitaxel in Patients With Platinum Refractory or Resistant Ovarian Cancer (NCT04055649) | Ira Winer | 2020-01-21 |
| Nab-Paclitaxel and Bevacizumab in Treating Patients With Unresectable Stage IV Melanoma or Gynecological Cancers (NCT02020707) | Mayo Clinic | 2014-02-24 |
| Changes in Brain Function in Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian, Primary Peritoneal, or Fallopian Tube Cancer Who Are Receiving Chemotherapy (NCT01080521) | Gynecologic Oncology Group | 2010-04-01 |
| Bevacizumab in Treating Patients With Recurrent Sex Cord-Stromal Tumors of the Ovary (NCT00748657) | National Cancer Institute (NCI) | 2008-09-22 |
| Collecting Tumor Samples From Patients With Gynecological Tumors (NCT00897442) | Gynecologic Oncology Group | 1992-06-01 |
Track Malignant Ovarian Epithelial Tumor automatically
Every clearance here is in the API, with alerts when new ones post.